Advertisement

Topics

Mylan launches 3 HIV generics in Canada

12:42 EDT 10 Aug 2017 | Drug Store News

Mylan has invested $250 million in expanding its antiretroviral production capabilities, enabling it to produce 4 billion antiretroviral tablets and capsules each year, the company said.

read more

Original Article: Mylan launches 3 HIV generics in Canada

NEXT ARTICLE

More From BioPortfolio on "Mylan launches 3 HIV generics in Canada"

Quick Search
Advertisement
 

Relevant Topics

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...